Rotator Cuff TearsNCT04361266
Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
A study testing Rotium nanoscaffold in people with Rotator Cuff Tears and Rotator Cuff Injuries, run by Joshua Szabo, MD.
Trial summary
The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders
- What is being tested?
- Rotium nanoscaffold
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2022to 1 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique.
- also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair)
- included age range of subjects will be from 18-80 years old
Who cannot join
- diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs)
- prior surgery to the ipsilateral rotator cuff tendon
- need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair
- significant glenohumeral arthritis
- active or ongoing infection
- pregnancy
About this study
The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population.
Hypothesis: Rotium rotator cuff repairs will heal both quicker and better than traditional rotator cuff repair techniques.
Read the detailed description
Patients indicated for rotator cuff repair surgery will be offered participation within the study and consented accordingly. A copy of the consent will be provided to the participant. A preoperative ultrasonographic assessment will occur by Dr. Onishi. A randomization process by computer program will determine patients who have Rotium augmented repairs, or not. The patients will not be blinded.
The surgery will be carried out by a single surgeon making all aspects uniform, except if there is or is not a Rotium patch. The Rotium patch will be implanted in accordance to standards of handling sterile implants and placed in a manner that is consistent to its FDA approval. The patch will be furnished by the institution where the surgery is being performed. Digital photography will document pertinent arthroscopic operative findings per standard of care.
Participant assessment will commence preoperatively in an outpatient clinic then continue in postoperative period, occurring at 2, 4, 6 weeks and 3, 6 and 12 month intervals. During each visit, the participants will be assessed by two clinicians: the principal investigator and a blinded ultrasonographer.
Preoperative assessment will include obtaining baseline patient reported outcomes (UCLA, Rowe, Constant, American Shoulder and Elbow Surgeons (ASES) score and SANE (Single Alpha Numeric Evaluation)scores) by paper questionnaire. A medical history will document NSAID use, cortisone injections about the shoulder, tobacco usage, narcotic medicine consumption, and pregnancy status. Due to their deleterious effects on healing, all patients will be instructed to not take NSAIDs in the first 6 weeks postoperative. Noncompliance will be noted, but not disqualify the participant from study. Smoking cessation will be strongly encouraged. A shoulder physical examination will be performed; specifically range of motion assessment in multiple planes (frontal flexion, internal and external rotation at 90 degrees of abduction and at side), rotator cuff muscle strength testing with the scapula stabilized, scapula posture observed, and provocative tests for impingement syndrome. Medical records will be reviewed. This evaluation will be performed by the principal investigator and will take 45-60 minutes. The participant will undergo a separate diagnostic ultrasonographic assessment of the rotator cuff tendons by blinded ultrasonographer. This will take 15-30 minutes.
Aftercare of each population will be identical and will include a 6-week period of sling immobilization, brief perioperative narcotic medicine, and physical therapy. Physical therapy protocols will be identical. The participants will be treated by a variety of physical therapists. All physical therapy will occur out of the home at a PT clinic. Additional home exercises will be furnished and will be independently performed by the participants.
Specifically, at the 2-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, VAS pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder assessed (frontal flexion and external rotation at the side), and the examine will exclude any complications. Physical therapy for shoulder passive range of motion and periscapular strengthening will be prescribed, home exercise sheet provided, and the abduction portion of the sling will be discontinued. Shoulder radiographs will be performed. This visit will take 15-30 minutes. In addition and separate to this,blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. Vascularity using superb microvascular imaging and standard ultrasound techniques will assess vascularity and rotator cuff repair integrity. If possible, elastography will be performed. These images will be stored in de-identified manner within University of Pittsburgh HIPPA-compliant cloud. This will take 15-30 minutes and may be done at a separate time.
At the 4-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion and external rotation at the side) assessed, and the examine will exclude any complications. The prior physical therapy and home exercises will be continued. This visit will take 15-30 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 6-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion, internal and external rotation at 90 degrees of abduction and at side) assessed, and the examine will exclude any complications. The sling will be discontinued and new physical therapy and home exercises will be provided; therapy will include shoulder passive range of motion and periscapular strengthening and include rotator cuff strengthening progressing from isometric to concentric then to eccentric with the pace being determined by a physical therapist, but done in a pain free manner. Additionally, patient reported outcomes (UCLA, Rowe, Constant, ASES and SANE scores) will be collected. This visit will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 3-, 6- and 12-month postoperative visits a history will be obtained to assess shoulder functionality/limitations, quantify NSAID usage, pain score, and assess for any complications. The examination will be similar to the 6-week evaluation, except rotator cuff specific strength will be assessed similar to the preoperative testing. Necessity of ongoing physical therapy will be considered and ordered appropriately. Home exercises will be continued. These visits will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
- Conditions
- Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders
- Being tested
- Rotium nanoscaffold, Control arm rotator cuff repair
- Medical subject headings
- Rotator Cuff Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rotium nanoscaffoldDevice
Rotium bioabsorbable nanoscaffold placed between bone-tendon interface of rotator cuff repair construct
Control arm rotator cuff repairProcedure or surgery
Standard rotator cuff repair without Rotium
| Study group | Role | What they receive |
|---|---|---|
| Rotium patch recipient | Experimental | Subjects with Rotium nano scaffold patch included in rotator cuff repair construct Receives: Device: Rotium nanoscaffold |
| Control | Active comparator | Subjects undergoing non-patch augmented rotator cuff repair Receives: Procedure: Control arm rotator cuff repair |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rotator cuff integrity baseline/preoperative
ultrasound assessment of rotator cuff
Measured: preoperative
Rotator cuff repair integrity @ 2 weeks
ultrasound assessment of rotator cuff
Measured: postoperative at 2 weeks
Rotator cuff repair integrity @ 4 weeks
ultrasound assessment of rotator cuff
Measured: postoperative at 4 weeks
Rotator cuff repair integrity @ 6 weeks
ultrasound assessment of rotator cuff
Measured: postoperative at 6 weeks
Rotator cuff repair integrity @ 3 months
ultrasound assessment of rotator cuff
Measured: postoperative 3 months
Rotator cuff repair integrity @ 6 months
ultrasound assessment of rotator cuff
Measured: postoperative at 6 months
Rotator cuff repair integrity @ 12 months
ultrasound assessment of rotator cuff
Measured: postoperative at 12 months
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 2 weeks
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 4 weeks
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 6 weeks
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 3 months
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 6 months
Postoperative rotator cuff vascularity during healing
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Measured: postoperative at 12 months
Secondary outcomes (5)
University California Los Angeles Shoulder score
Outcome score
Measured: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Rowe score
Outcome score
Measured: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Constant score
Outcome score
Measured: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
American shoulder and elbow surgeons score
Outcome score
Measured: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
SANE score
Outcome score
Measured: preoperative and postoperative at 2,4, 6 weeks and 3,6,12 months postoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2020
- Study start1 Aug 2022 (estimated)
- Primary completion1 Aug 2023 (estimated)
- Study completion1 Nov 2023 (estimated)
Why it stopped: withdrawn
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rotator Cuff TearsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- prospective randomized control trial
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Joshua Szabo, MD
- Sponsor type
- University, hospital or other
- Collaborators
- Atreon Orthopedics
- Responsible party
- Sponsor-investigator, Joshua Szabo, MD, University of Pittsburgh
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04361266
- Sponsor's protocol ID
- STUDY19080165
- Status last verified
- Oct 2022
- First submitted
- 17 Apr 2020
- Last updated
- 18 Oct 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to share data at this time.
Study at a glance
From the registry record, last updated by the sponsor on 18 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
- ClinicalTrials.gov ID
- NCT04361266
- Acronym / sponsor ID
- STUDY19080165
- Conditions
- Rotator Cuff Tears, Rotator Cuff Injuries, Rotator Cuff Syndrome of Shoulder and Allied Disorders
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: withdrawn
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Joshua Szabo, MDUniversity, hospital or other
- Collaborators
- Atreon Orthopedics
- Study start
- 1 Aug 2022 (estimated)
- Primary completion
- 1 Aug 2023 (estimated)
- Study completion
- 1 Nov 2023 (estimated)
- First posted
- 24 Apr 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose is to assess Rotium, a novel nanoscaffold, impact on healing of a repaired rotator cuff and compare to a repair without Rotium. Animal (sheep) models have shown both quicker and more organized healing when Rotium is used, but there are no studies to confirm these outcomes translate to human population.
Hypothesis: Rotium rotator cuff repairs will heal both quicker and better than traditional rotator cuff repair techniques.
Detailed description
Patients indicated for rotator cuff repair surgery will be offered participation within the study and consented accordingly. A copy of the consent will be provided to the participant. A preoperative ultrasonographic assessment will occur by Dr. Onishi. A randomization process by computer program will determine patients who have Rotium augmented repairs, or not. The patients will not be blinded.
The surgery will be carried out by a single surgeon making all aspects uniform, except if there is or is not a Rotium patch. The Rotium patch will be implanted in accordance to standards of handling sterile implants and placed in a manner that is consistent to its FDA approval. The patch will be furnished by the institution where the surgery is being performed. Digital photography will document pertinent arthroscopic operative findings per standard of care.
Participant assessment will commence preoperatively in an outpatient clinic then continue in postoperative period, occurring at 2, 4, 6 weeks and 3, 6 and 12 month intervals. During each visit, the participants will be assessed by two clinicians: the principal investigator and a blinded ultrasonographer.
Preoperative assessment will include obtaining baseline patient reported outcomes (UCLA, Rowe, Constant, American Shoulder and Elbow Surgeons (ASES) score and SANE (Single Alpha Numeric Evaluation)scores) by paper questionnaire. A medical history will document NSAID use, cortisone injections about the shoulder, tobacco usage, narcotic medicine consumption, and pregnancy status. Due to their deleterious effects on healing, all patients will be instructed to not take NSAIDs in the first 6 weeks postoperative. Noncompliance will be noted, but not disqualify the participant from study. Smoking cessation will be strongly encouraged. A shoulder physical examination will be performed; specifically range of motion assessment in multiple planes (frontal flexion, internal and external rotation at 90 degrees of abduction and at side), rotator cuff muscle strength testing with the scapula stabilized, scapula posture observed, and provocative tests for impingement syndrome. Medical records will be reviewed. This evaluation will be performed by the principal investigator and will take 45-60 minutes. The participant will undergo a separate diagnostic ultrasonographic assessment of the rotator cuff tendons by blinded ultrasonographer. This will take 15-30 minutes.
Aftercare of each population will be identical and will include a 6-week period of sling immobilization, brief perioperative narcotic medicine, and physical therapy. Physical therapy protocols will be identical. The participants will be treated by a variety of physical therapists. All physical therapy will occur out of the home at a PT clinic. Additional home exercises will be furnished and will be independently performed by the participants.
Specifically, at the 2-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, VAS pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder assessed (frontal flexion and external rotation at the side), and the examine will exclude any complications. Physical therapy for shoulder passive range of motion and periscapular strengthening will be prescribed, home exercise sheet provided, and the abduction portion of the sling will be discontinued. Shoulder radiographs will be performed. This visit will take 15-30 minutes. In addition and separate to this,blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. Vascularity using superb microvascular imaging and standard ultrasound techniques will assess vascularity and rotator cuff repair integrity. If possible, elastography will be performed. These images will be stored in de-identified manner within University of Pittsburgh HIPPA-compliant cloud. This will take 15-30 minutes and may be done at a separate time.
At the 4-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion and external rotation at the side) assessed, and the examine will exclude any complications. The prior physical therapy and home exercises will be continued. This visit will take 15-30 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 6-week postoperative visit a history will be obtained to quantify narcotic usage, NSAID usage, pain score, and assess for any complications. The surgical site and sling will be inspected, passive range of motion of the shoulder (frontal flexion, internal and external rotation at 90 degrees of abduction and at side) assessed, and the examine will exclude any complications. The sling will be discontinued and new physical therapy and home exercises will be provided; therapy will include shoulder passive range of motion and periscapular strengthening and include rotator cuff strengthening progressing from isometric to concentric then to eccentric with the pace being determined by a physical therapist, but done in a pain free manner. Additionally, patient reported outcomes (UCLA, Rowe, Constant, ASES and SANE scores) will be collected. This visit will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
At the 3-, 6- and 12-month postoperative visits a history will be obtained to assess shoulder functionality/limitations, quantify NSAID usage, pain score, and assess for any complications. The examination will be similar to the 6-week evaluation, except rotator cuff specific strength will be assessed similar to the preoperative testing. Necessity of ongoing physical therapy will be considered and ordered appropriately. Home exercises will be continued. These visits will take 30-45 minutes. In addition and separate to this, blinded ultrasonographer will perform ultrasound assessment of the repaired rotator cuff. This will take 15-30 minutes and may be done at a separate time.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
- Model description
- prospective randomized control trial
| Arm | Type | Receives |
|---|---|---|
| Rotium patch recipient | Experimental | Device: Rotium nanoscaffoldSubjects with Rotium nano scaffold patch included in rotator cuff repair construct |
| Control | Active comparator | Procedure: Control arm rotator cuff repairSubjects undergoing non-patch augmented rotator cuff repair |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- -symptomatic supraspinatus or supraspinatus and infraspinatus tear that can be repaired to the greater tuberosity in an anatomical manner using a dual layer repair technique.
- also included will be patients that have concomitant pathology addressed at time of surgery, specifically pathologies of the biceps tendon (tenodesis or tenotomy), arthrosis of the acromioclavicular joint (distal clavicle resection), or labral tearing (debridement or repair)
- included age range of subjects will be from 18-80 years old
Key exclusion criteria (6 listed)
- diabetes, cancer or medical states that may impair healing, such as organ transplantation or systemic inflammatory process treated with immune modulating drugs (chemotherapy, immunosuppression drugs)
- prior surgery to the ipsilateral rotator cuff tendon
- need of soft tissue releases to accomplish an anatomic repair, partial repairs and/or concomitant subscapularis repair
- significant glenohumeral arthritis
- active or ongoing infection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rotium nanoscaffoldRotium bioabsorbable nanoscaffold placed between bone-tendon interface of rotator cuff repair construct | Device | Rotium patch recipient |
| Control arm rotator cuff repairStandard rotator cuff repair without Rotium | Procedure or surgery | Control |
Primary outcome
Rotator cuff integrity baseline/preoperative
Time frame: preoperative
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 2 weeks
Time frame: postoperative at 2 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 4 weeks
Time frame: postoperative at 4 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 weeks
Time frame: postoperative at 6 weeks
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 3 months
Time frame: postoperative 3 months
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 6 months
Time frame: postoperative at 6 months
ultrasound assessment of rotator cuff
Rotator cuff repair integrity @ 12 months
Time frame: postoperative at 12 months
ultrasound assessment of rotator cuff
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 2 weeks
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 4 weeks
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 6 weeks
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 3 months
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 6 months
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
Postoperative rotator cuff vascularity during healing
Time frame: postoperative at 12 months
ultrasound assessment of rotator cuff at repair site using superb microvascular imaging (SMI)
5 secondary outcomes
University California Los Angeles Shoulder score
Time frame: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Rowe score
Time frame: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
Constant score
Time frame: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
American shoulder and elbow surgeons score
Time frame: preoperative and postoperative at 6 weeks and 3,6,12 months postoperative
SANE score
Time frame: preoperative and postoperative at 2,4, 6 weeks and 3,6,12 months postoperative
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Oct 2022.
- Individual participant dataSharing planned: No. There is no plan to share data at this time.
Related trials for Rotator Cuff Tears
Active, not recruitingPhase 1
E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
Rotator Cuff Tears, Muscle Atrophy or Weakness
Not yet recruiting
Voll Non-Degradable Shoulder Spacer FIH Study
Massive Rotator Cuff Tears, Massive Rotator Cuff Tear
Active, not recruitingPhase 2
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Orthopedics, Traumatology
Recruiting
SMR Stemless Reverse vs SMR Reverse Shoulder System
Arthroplasty, Replacement
Active, not recruiting
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
Rotator Cuff Tears
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Rotium nanoscaffold in people with Rotator Cuff Tears and Rotator Cuff Injuries, run by Joshua Szabo, MD.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 18 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rotator cuff integrity baseline/preoperative (time frame: preoperative). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2022.